Heart Transplant Rejection
📧 Sign up to get email alerts when something new happens for Heart Transplant Rejection.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2016-05-26FDA Approved: CELLCEPT — Supplemental Application (Genentech, Inc.)
FDA approved a supplemental application for CELLCEPT (mycophenolate mofetil) submitted by Genentech, Inc. The action authorizes changes unde…
-
CLINICAL_TRIALS withdrawal · 2016-05-26Clinical Trial Update: Acute Heart Graft Rejection Screening by Cardiac Magnetic Resonance Imaging [NA]
The clinical trial NCT02400840 on acute heart graft rejection screening using cardiac magnetic resonance imaging has been withdrawn.
-
FDA approval · 2016-01-22FDA Approved: TACROLIMUS — Supplemental Application (Strides Pharma Science Limited)
The FDA approved a supplemental application for tacrolimus from Strides Pharma Science Limited.
-
FDA approval · 2015-11-13FDA Approved: MYCOPHENOLATE MOFETIL — Supplemental Application (Accord Healthcare Inc.)
The FDA approved a supplemental application for Accord Healthcare's mycophenolate mofetil, a generic immunosuppressant, to support its use i…
-
FDA approval · 2015-11-13FDA Approved: MYCOPHENOLATE MOFETIL — Supplemental Application (Ascend Laboratories, LLC)
The FDA approved a supplemental application for mycophenolate mofetil submitted by Ascend Laboratories, LLC.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2015-11-13FDA Approved: MYCOPHENOLATE MOFETIL — Supplemental Application (Ascend Laboratories, LLC)
The FDA approved a supplemental application for mycophenolate mofetil from Ascend Laboratories, LLC.
-
FDA approval · 2015-11-13FDA Approved: MYCOPHENOLATE MOFETIL — Supplemental Application (Strides Pharma Science Limited)
The FDA approved a supplemental application to allow Strides Pharma Science Limited to market a generic mycophenolate mofetil. This approval…
-
FDA approval · 2015-11-09FDA Approved: MYCOPHENOLATE MOFETIL — Supplemental Application (Sandoz Inc)
FDA approved a supplemental application for mycophenolate mofetil from Sandoz Inc under an ANDA, authorizing changes to the product labeling…
-
FDA approval · 2015-11-06FDA Approved: MYCOPHENOLATE MOFETIL — Supplemental Application (Accord Healthcare Inc.)
FDA approved Accord Healthcare's supplemental application for mycophenolate mofetil (generic) under an existing ANDA.
-
FDA label_change · 2015-11-06FDA Approved: MYCOPHENOLATE MOFETIL — Supplemental Application (Accord Healthcare Inc.)
FDA supplemental approval for mycophenolate mofetil by Accord Healthcare Inc., resulting in labeling changes for the product.
-
FDA approval · 2015-10-30FDA Approved: MYCOPHENOLATE MOFETIL — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved Hikma Pharmaceuticals USA Inc.'s supplemental application for mycophenolate mofetil, enabling generic manufacturing and marketi…
-
FDA approval · 2015-10-13FDA Approved: TACROLIMUS — Supplemental Application (Quallent Pharmaceuticals Health LLC)
FDA approved a supplemental application for tacrolimus from Quallent Pharmaceuticals Health LLC, approving a generic formulation for use in …
-
CLINICAL_TRIALS trial_result · 2015-09-01Clinical Trial Update: Cardiac Magnetic Resonance Imaging (CMRI) for Detection of Cardiac Transplant Rejection
This completed clinical trial evaluated cardiac magnetic resonance imaging for detecting heart transplant rejection.
-
CLINICAL_TRIALS trial_result · 2015-08-27Clinical Trial Update: Elimination of Cardiac and Inflammatory Biomarkers and Adipokines by Therapeutic Plasma Exchange
A completed clinical trial evaluating whether therapeutic plasma exchange reduces cardiac and inflammatory biomarkers and adipokines in cont…
-
FDA approval · 2015-08-12FDA Approved: ENVARSUS XR — Supplemental Application (Veloxis Pharmaceuticals, Inc)
The FDA approved a supplemental application for ENVARSUS XR (tacrolimus) filed by Veloxis Pharmaceuticals, authorizing changes to the NDA vi…
-
FDA approval · 2015-07-09FDA Approved: CELLCEPT — Supplemental Application (Genentech, Inc.)
FDA approved a supplemental application for CELLCEPT (mycophenolate mofetil hydrochloride) submitted by Genentech, Inc.
-
FDA approval · 2015-07-09FDA Approved: CELLCEPT — Supplemental Application (Genentech, Inc.)
FDA approved a supplemental application for CellCept (mycophenolate mofetil) submitted by Genentech, Inc.
-
CLINICAL_TRIALS research · 2015-04-07Clinical Trial Update: Heartsbreath Test for Heart Transplant Rejection
Clinical trial update on the Heartsbreath test from Menssana Research for detecting heart transplant rejection.
-
FDA approval · 2014-11-14FDA Approved: MYCOPHENOLATE MOFETIL — Original Application (Ascend Laboratories, LLC)
FDA approved an original application for a generic version of mycophenolate mofetil from Ascend Laboratories, intended to prevent organ tran…
-
FDA approval · 2014-06-26FDA Approved: MYCOPHENOLIC ACID — Supplemental Application (Apotex Corp)
The FDA approved a supplemental application for mycophenolic acid from Apotex Corp.
-
FDA approval · 2014-02-27FDA Approved: TACROLIMUS — Supplemental Application (Sandoz Inc.)
The FDA approved a supplemental application for tacrolimus from Sandoz Inc., a generic immunosuppressant used to prevent organ rejection in …
-
FDA approval · 2014-01-08FDA Approved: MYCOPHENOLIC ACID — Original Application (Archis Pharma LLC)
FDA approved Archis Pharma LLC's original application for mycophenolic acid, granting approval of a generic version for use in preventing or…
-
FDA approval · 2014-01-08FDA Approved: SIROLIMUS — Original Application (Zydus Pharmaceuticals USA Inc.)
FDA approves an original generic application for sirolimus from Zydus Pharmaceuticals USA Inc., establishing a generic version of the immuno…
-
FDA approval · 2013-09-27FDA Approved: CELLCEPT — Supplemental Application (Genentech, Inc.)
The FDA approved a supplemental application for CELLCEPT (mycophenolate mofetil) submitted by Genentech.
-
FDA label_change · 2013-09-27FDA Approved: MYFORTIC — Supplemental Application (Novartis Pharmaceuticals Corporation)
FDA approved a supplemental application for Myfortic (mycophenolic acid) from Novartis. The approval updates the labeling to reflect changes…